Yunnan Alphy Biotech Co., Ltd, found in 2007, is a high-tech enterprise engaged in the commercial cultivation of Haematococcus pluvialis. In 2013, Yunnan Alcom Biotech Co., Ltd was found as its whole subsidiary, engaged in the extraction of natural astaxanthin derived from H.pluvialis and marketing. In 2015, Alphy was listed on NEEQ (Stock Code: 834118) and became a public company since then.
Having started from cell engineering, the company developed a new business model by using barren hill as its’ base site to cultivate microalgae and produce high value natural astaxanthin products. After years’ efforts, Alphy’s technologies have reached up to the top level in this area. Meanwhile, the company got 20 patents as the pioneer in developing microalgae
cultivation. In addition, the National R&D Center of H.pluvialis was built in Alphy, released by NDRC (National Development and Reform Commission).
Core Value: Diligence, Integrity, Unity, Creation, Customer Satisfaction, Social Responsibility
Vision: We are dedicated to building a microalgae industrial base and providing healthy products that improve human living.